PATENTS

U.S. Patent No. 8,552,364, filed March 16, 2010 as “SERUM PROTEOMICS SYSTEM AND ASSOCIATED METHODS”

 

U.S. Provisional Patent Application No. 62/529,313 filed July 6, 2017 as “Serum Peptide biomarker profiles associated with breast cancer metastasis”

 

U.S. Patent Application No. PCT/US2016/058824 filed Oct 26, 2016 as “Serum lipid biomarkers for preeclampsia prediction”

 

U.S. Patent Application No. PCT/US17/40992 filed July 6, 2017 as “Serum lipid biomarkers that diagnose Alzheimer’s disease”

 

U.S. Patent Application No. 15/323,718 as “Systems and Assays for Determining Risk Factors for Alzheimer’s Disease

 

U.S. Patent Application No. 12/669343 as “Identification and Quantification of Biomarkers for Evaluating the Risk of Preterm Birth”

PUBLICATIONS

Anand S, Barnes JM, Young SA, Garcia DM, Tolley HD, Kauwe JSK, Graves SW. Discovery and confirmation of diagnostic serum lipid biomarkers for Alzheimer’s disease using direct infusion mass spectrometry.  J Alzheimer’s Dis  (2017) ;59:277-290.

 

Graves, S. W., Kang, H., Roeder, B. L., Martin, H. M., Anand, S., Cook, A. C., Lau, C. Y., Buckmiller, E. M., Brown, K. K., Eggett, D. L. (2017). Discovery and confirmation of diagnostic serum lipid biomarkers for Alzheimer’s disease using direct infusion mass spectrometry.. J Alzheimer’s Dis.

 

Kang, H., Roeder, B. L., Martin, H. M., Anand, S., Cook, A. C., Lau, C. Y., Buckmiller, E. M., Brown, K. K., Eggett, D. L., Graves, S. W. (2017). A lipidomic approach reveals colostrum and milk biomarkers predictive of production-related metabolic disease.. Journal of Agriculture Life Sciences, 4(1), 1-15

 

Anand, S., Barnes, J. M., Young, S. A., Garcia, D. M., Tolley, H. D., Kauwe, J. S. K., Graves, S. W. (2017). Discovery and confirmation of diagnostic serum lipid biomarkers for Alzheimer's disease using direct infusion mass spectrometry. Journal of Alzheimer's Disease, 59(2017), 277-290.

 

Shah, D., Rohlfing, F., Anand, S., Johnson, W. E., Alvarez, M. T., Cobell, J., King, J., Young, S. A., Kauwe, J. S. K., Graves, S. W. (2016). Discovery and Subsequent Confirmation of Novel Serum Biomarkers Diagnosing Alzheimer’s Disease. Journal of Alzheimer's Disease, 49(2), 317-327. 1

 

Kedia, K., Smith, S. F., Wright, A. H., Barnes, J. M., Tolley, H. D., Esplin, M. S., Graves, S. W. (2016). Global "omics" evaluation of human placental responses to preeclamptic conditions. American Journal of Obstetrics and Gynecology, 215.

 

Anand, S., Young, S. A., Esplin, M. S., Peaden, B., Tolley, H. D., Porter, T. F., Varner, M. W., D'Alton, M. E., Jackson, B. J., Graves, S. W. (2016). Detection and confirmation of serum lipid biomarkers for preeclampsia using direct infusion mass spectrometry. Journal of Lipid Research, 57(4), 687-696.

 

Kedia, K., Smith, S. F., Wright, A. H., Barnes, J. M., Tolley, H. D., Esplin, M. S., Graves, S. W. (2016). Global "omics" evaluation of human placental responses to preeclamptic conditions. American Journal of Obstetrics and Gynecology. dx.doi.org/10.1016/j.ajog.2016.03.004

 

Esplin MS, Merrell K, Goldenberg R, Lai Y, Iams JD, Mercer B, Spong CY, Miodovnik M, Simhan HN, Van Dorsten P, Dombrowski M. Proteomic identification of serum peptides predicting subsequent spontaneous preterm birth. Amer J Obstet Gynecol

 

Merrell K, Thulin CD, Esplin MS, Graves SW. An integrated serum proteomic approach capable of monitoring the low molecular weight proteome with sequencing of intermediate to large peptides. Rapid Comm Mass Spectrom 2009;23:2685-2696

 

Merrell K, Southwick K, Graves SW, Esplin MS, Lewis NE, Thulin CD. Analysis of lowabundance, low-molecular-weight serum proteins using mass spectrometry. J Biomolec Techniques 2004;15:235-244

© 2018 by Magellan Bioanalytics